A method of treating diarrhea or an inflammatory condition of the gut in a subject comprises administering a therapeutically effective amount of beta-hydroxy-beta-methylbutyrate (HMB) or a salt thereof to a subject in need thereof. A method of treating secretory diarrhea in a subject comprises administering a therapeutically effective amount of HMB or a salt thereof to a subject exhibiting one or more of the following symptoms: loss of fluids from the gut, loss of electrolytes from the gut, dehydration, or inflammation of the intestinal tract.

An object of the present invention is to provide an enzyme-treated milk product, a method for preparing the same, a composition thereof comprising a pharmaceutical composition, and a product thereof comprising a pharmaceuticals. The enzyme-treated milk product can be obtained by a method for producing an enzyme-treated milk product including a step for bringing milk into contact with β-galactosidase.

An object of the present invention is to provide an enzyme-treated milk product, a method for preparing the same, a composition thereof comprising a pharmaceutical composition, and a product thereof comprising a pharmaceuticals. The enzyme-treated milk product can be obtained by a method for producing an enzyme-treated milk product including a step for bringing milk into contact with β-galactosidase.

Provided is a beverage composition, including: non-polymer catechins; and caffeine, the beverage composition satisfying the following requirements (A), (B), and (C): (A) a mass ratio of caffeine/non-polymer catechins is 0.180 or less; (B) particles contained in the beverage composition have an average particle size of 3 μm or less; and (C) a turbidity is 30 NTU or more.

An aromatizing material is disclosed that has green layer aroma and makes one feel its aroma in a sustained way. The tea aromatizing liquid composition comprises dimethyl sulfide and β-ionone, and has a weight ratio of β-ionone content to dimethyl sulfide content which is adjusted to be in the range of from 0.01 to 3.5.

Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.

2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD), as well as variants, derivatives, analogs, modifications, and conjugates thereof, are identified as therapeutic agents for treating or preventing human cancers and precancerous conditions. DMDD can be isolated from the root of Averrhoa carambola L., commonly known as starfruit. Pharmaceutical and nutraceutical compositions, as well as dietary supplements, are provided, as are methods of administration and treatment.

An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.

An apparatus for accommodating a beverage includes an outer vessel defining a vessel cavity for receiving a cooling agent, a container having a lid and a beverage receptacle and a port. The lid is configured for engagement with the outer vessel to releasably mount the container to the outer vessel. The beverage receptacle defines a receptacle chamber for accommodating a liquid beverage for consumption by a user. The receptacle chamber is isolated from the vessel cavity. The beverage receptacle comprises a thermal conductive material and is at least partially disposed within the vessel cavity of the outer vessel when the container is mounted to the outer vessel whereby thermal energy is transferred from the cooling agent to the liquid beverage. The port defines a port opening in fluid communication with the receptacle chamber to permit distribution of the liquid beverage to the user. The outer vessel and mounted container may be positioned within a freezing apparatus to freeze the cooling agent, e.g., water about the beverage receptacle.

An apparatus for accommodating a beverage includes an outer vessel defining a vessel cavity for receiving a cooling agent, a container having a lid and a beverage receptacle and a port. The lid is configured for engagement with the outer vessel to releasably mount the container to the outer vessel. The beverage receptacle defines a receptacle chamber for accommodating a liquid beverage for consumption by a user. The receptacle chamber is isolated from the vessel cavity. The beverage receptacle comprises a thermal conductive material and is at least partially disposed within the vessel cavity of the outer vessel when the container is mounted to the outer vessel whereby thermal energy is transferred from the cooling agent to the liquid beverage. The port defines a port opening in fluid communication with the receptacle chamber to permit distribution of the liquid beverage to the user. The outer vessel and mounted container may be positioned within a freezing apparatus to freeze the cooling agent, e.g., water about the beverage receptacle.